Mungo Park
Position/Department/Division/Institution/Organization
Founder and Chair, Innovator Capital Limited (ICL)Country
United Kingdom
Career history
1973 – 1974

Bache & Co., London
Institutional Equity Sales
Reported to Alfred Elbrick, and worked with him covering English, Scottish
and Irish institutional investors. We both left the firm at the same time. I
needed stock exchange experience.

1974 - 1975

Kitcat & Aitken, London
London Stock Exchange and Eurobonds
Reported to Max Neilsen, spent a year working on the floor of the stock
exchange and a year working in the Eurobond Department. Obtained theexperience and went to America to work again with Alfred Elbrick.

1975 - 1979

Alex. Brown & Sons,Baltimore, MD, UDA

Institutional Equity Sales, ICT, Biotech and Pharma
Covered institutional investors on a Pan European basis, interacting daily
with trading, research, syndicate and corporate executives.
1979 - 1981

Dillon Read & Co., London & New York
Institutional Equity Sales and Research, ICT
Reported to Evan Galbraith and launched Gartner Group Research in Europe,
pure ICT investment banking. Gartner became the world’s leading
independent ICT research house. Originated and implemented hugely
successful, first of its kind business model. Galbraith appointed U.S.
Ambassador to France, control of my division moved to New York – became
unworkable.

Innovation for Cool Earth Forum (ICEF)
7th Annual Meeting － Virtual Forum ―1981 - 1987

Wertheim & Co., London & New York
Opened London Office, Investment Banking, ICT, Biotech and Pharma
Recruited by Gerry Kaminsky. Built the operation from scratch with novel
marketing approach given we were the 43 rd U.S. bank to open in London.
Financially very rewarding, as the crash of 1987 came and with 14 years of
total commitment to investment banks, I decided to work as an independentadviser.

1987 - 1995

Independent Adviser, London
Medeva Plc.
Active Analysis
Invested in and advised a number of companies. Of particular interest wasworking with Bernard Taylor, ex CEO of GSK, on a novel vaccine
manufacturing platform and setting up new pharmaceutical company called
Medeva Plc. Also set up a software company, doing big data analysis. Sold
company to a U.S. Government contractor.

1995 - 1997

Cowen & Co., London, Boston & New York
Investment Banking, ICT, Biotech and Pharma
Recruited again by Gerry Kaminsky. Cowen was the top healthcare IPO firmon Wall Street and a leader in ICT. Gerry wanted my experience in thebusiness and the sector. U.S. inv. Banking began to lose its way and mygrowing conviction that the model lacked integrity made me look elsewhereto implement a new business model. Nomura approached me and offered theopportunity.

1997 - 1999

Nomura International Plc, London
Investment Banking, Biotech, Pharma and ICTAs Head of Corporate Finance, worldwide, for three sectors, implemented
new investment banking model. Built team from scratch, with Principal
Finance strategy and integrated it with traditional disciplines under thesame P&L. We put our money at risk alongside the investment clients.
Thereby aligning interests. Raised over $500 million for cancer related
projects. Left Nomura after Russia defaulted on western debt, costing
Nomura $3billion and Tokyo HQ wanting to revert to old business model.
Innovation for Cool Earth Forum (ICEF)
7th Annual Meeting － Virtual Forum ―1999 - 2001

Portfin.com Limited, London
Fintech Start Up
Set up internet company to provide “white label” platform for small tomedium sized brokers and investment managers to offer to their customers.
I chose the wrong partner and resigned from the company. (Moreinformation on request)

2001 - 2003

Columbus Asset Management London
Navigator Asset Management (Chair)
Worked with both companies to develop novel - in the UK - corporate financemodels. One a revenue-based royalty model to provide funding for
Bio/Pharma companies, the other, a non-toxic version of the American equity
line of credit.

2003 - Present

Innovator Capital Limited (“ICL”), (Founder and Chair)
Investment Banking, Health and Sustainability Technology Innovation
ICL is a London based specialist investment bank, founded by Mungo in 2003.
The focus is on acceleration of sustainable technology innovation;technologies which rapidly impact the causes and consequences of climatechange. ICL provides, corporate finance, M&A, technology transfer,intellectual property and strategic advisory services to the innovators.
ICL was originally founded to advise Life-Science companies; by 2004
Mungo concluded that he would not find a cure for asthma in his lifetime so
set about looking for technologies that could address air pollution, anaggravator of paediatric asthma, particularly from heavy-duty vehicles inurban areas. It then became obvious that sustainable, resource efficient andclean technologies in air, water, food and energy were essential to quality oflife. ICL added sustainable technologies to its area of specialisation; aprophylactic and therapeutic approach to some of world’s greatest threats.
In 2007 Mungo and His Serene Highness Prince Albert founded
CleanEquity® Monaco; which is now one of the world’s premier, sustainable
technology conferences. Over 600 technologies every year are sourced; 30 ofthem, meeting strict, key criteria, are selected to attend and potentially, beInnovation for Cool Earth Forum (ICEF)
7th Annual Meeting － Virtual Forum ―clients for ICL. To date, some 350 technologies, from over 30 countries, havebeen shown to interested parties from around the world.
In 2011, determined to raise awareness of sustainability further, ICL involved
the Nobel name in CleanEquity® Monaco. Working closely with the newly
created Nobel Sustainability® Trust and with His Serene Highness, the Nobel
Sustainability® Fund was launched in 2016. It is the world’s first multi-phase,
multi-technology and multi-geography sustainable technology fund.
Other appointments
2006 - 2019

CDTi, Inc. (NASDAQ, sustainable technology innovation company) California,Director, Chair and Chair of Audit Committee

2008 - 2017

Heart Metabolics, Director

2010 - 2014

Climate Change Forum participant, UK Minister, Energy and Climate Change

2019 - Present

Director, MagneGas, sustainable technology innovation company, Ireland
LimitedAreas of expertise
Forty-five years of experience in investment banking/advisory. Industry specialisation includes
the United Nations Sustainable Development Goals with a particular focus on technologicalinnovation in sustainability, health, and information and communication technology (ICT).

Innovation for Cool Earth Forum (ICEF)
7th Annual Meeting － Virtual Forum ―